معرفی
Caroline Bergenfelz is a researcher at Lund University (Cancer Immunology, Malmö) and Principal Investigator at LUCC: Lund University Cancer Centre. She also serves as a Project Coordinator for Infect@LU.
- Key Collaborations: Lund University Cancer Centre (LUCC), Allmänna Sjukhusets i Malmö Stiftelse för bekämpande av Cancer
- Projects: High-resolution tumor-immune interaction mapping (2025-2027), Spatial immune landscape in metastases (2025-2026), HAMLET bacterial death mechanisms (since 2017)
Her research spans cancer immunology and microbiology, focusing on:
- Tumor-associated macrophages and monocytes in breast cancer
- Inflammatory response modulation by respiratory microbiota
- Gene expression profiling for metastatic prognosis
- Apoptotic pathway regulation in tumor microenvironment
- Clinical immuno-oncology biomarkers
- Microbial ecology in cancer progression
Article trends show strong emphasis on breast cancer immunology (CD163+ cells, TAM/TAN interactions) and microbiota-cancer crosstalk (Corynebacterium species, inflammation modulation).
She actively contributes to academic events, including:
- Co-organizing LUCC-Malmö Cancer Seminars (2024)
- Collaborations with 10+ researchers across Sweden
۰مقاله منتشرشده
